Costs, favourable outcomes*, and incremental cost-effectiveness ratios of the different strategies, ranked by increasing effectiveness (per 100000 live births)
| Strategy | Total costs (£) | Total favourable outcomes | Additional costs (£)† [A] | Additional favourable outcomes† [B] | Incremental cost-effectiveness ratio (£)† [A/B] |
|---|---|---|---|---|---|
| *Favourable outcome refers to radiological appearances at skeletal maturity of Severin grades 1, 2, or 3. | |||||
| †Compared with no screening. | |||||
| No screening | 380596 | 89.90 | – | – | – |
| Clinical screening alone | 1014537 | 94.05 | 633941 | 4.15 | 152757 |
| Selective ultrasound | 2841295 | 106.15 | 2460699 | 16.25 | 151428 |
| Universal ultrasound | 4394515 | 110.83 | 4013919 | 20.93 | 191778 |